Study of relationship between dose, LET and the risk of brain necrosis after proton therapy for skull base tumors

被引:19
|
作者
Garbacz, Magdalena [1 ]
Cordoni, Francesco Giuseppe [2 ,3 ]
Durante, Marco [4 ,5 ]
Gajewski, Jan [1 ]
Kisielewicz, Kamil [6 ]
Krah, Nils [7 ,12 ]
Kopec, Renata [1 ]
Olko, Pawel [1 ]
Patera, Vincenzo [8 ,9 ]
Rinaldi, Ilaria [10 ]
Rydygier, Marzena [1 ]
Schiavi, Angelo [9 ]
Scifoni, Emanuele [3 ]
Skora, Tomasz [6 ]
Tommasino, Francesco [3 ,11 ]
Rucinski, Antoni [1 ]
机构
[1] Polish Acad Sci, Inst Nucl Phys, PL-31342 Krakow, Poland
[2] Univ Verona, Dept Comp Sci, Verona, Italy
[3] TIFPA INFN, Trento Inst Fundamental Phys & Applicat, Trento, Italy
[4] GSI Helmholtzzentrum Schwerionenforsch, Darmstadt, Germany
[5] Tech Univ Darmstadt, Darmstadt, Germany
[6] Natl Oncol Inst, Natl Res Inst, Krakow Branch, Krakow, Poland
[7] Univ Lyon 1, Univ Lyon, Ctr Leon Berard, INSA Lyon,CREATIS,CNRS UMR5220,Inserm U1044,INSA, Lyon, France
[8] Ist Nazl Fis Nucl, Sect Rome, Rome, Italy
[9] Sapienza Univ Rome, Dept Basic & Appl Sci Engn, Rome, Italy
[10] Maastricht Univ, GROW Sch Oncol, Dept Radiat Oncol Maastro, Med Ctr, Maastricht, Netherlands
[11] Univ Trento, Dept Phys, Trento, Italy
[12] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, IN2P3,IP21 Lyon,UMR 5822, Villeurbanne, France
关键词
Brain necrosis; Linear energy transfer; Monte Carlo; Proton therapy; Variable RBE; RELATIVE BIOLOGICAL EFFECTIVENESS; EFFECTIVENESS RBE VALUES; TEMPORAL-LOBE NECROSIS; CLINICAL-EVIDENCE; CANCER-PATIENTS; NORMAL TISSUE; RADIOTHERAPY;
D O I
10.1016/j.radonc.2021.08.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We investigated the relationship between RBE-weighted dose (DRBE) calculated with constant (cRBE) and variable RBE (vRBE), dose-averaged linear energy transfer (LETd) and the risk of radiographic changes in skull base patients treated with protons. Methods: Clinical treatment plans of 45 patients were recalculated with Monte Carlo tool FRED. Radiographic changes (i.e. edema and/or necrosis) were identified by MRI. Dosimetric parameters for cRBE and vRBE were computed. Biological margin extension and voxel-based analysis were employed looking for association of DRBE(vRBE) and LETd with brain edema and/or necrosis. Results: When using vRBE, Dmax in the brain was above the highest dose limits for 38% of patients, while such limit was never exceeded assuming cRBE. Similar values of Dmax were observed in necrotic regions, brain and temporal lobes. Most of the brain necrosis was in proximity to the PTV. The voxel-based analysis did not show evidence of an association with high LETd values. Conclusions: When looking at standard dosimetric parameters, the higher dose associated with vRBE seems to be responsible for an enhanced risk of radiographic changes. However, as revealed by a voxel-based analysis, the large inter-patient variability hinders the identification of a clear effect for high LETd. (c) 2021 The Authors. Published by Elsevier B.V. Radiotherapy and Oncology 163 (2021) 143-149 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:143 / 149
页数:7
相关论文
共 50 条
  • [1] Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base
    Kitpanit, Sarin
    Lee, Anna
    Pitter, Ken L.
    Fan, Dan
    Chow, James C. H.
    Neal, Brian
    Han, Zhiqiang
    Fox, Pamela
    Sine, Kevin
    Mah, Dennis
    Dunn, Lara A.
    Sherman, Eric J.
    Michel, Loren
    Ganly, Ian
    Wong, Richard J.
    Boyle, Jay O.
    Cohen, Marc A.
    Singh, Bhuvanesh
    Brennan, Cameron W.
    Gavrilovic, Igor T.
    Hatzoglou, Vaios
    O'Malley, Bernard
    Zakeri, Kaveh
    Yu, Yao
    Chen, Linda
    Gelblum, Daphna Y.
    Kang, Jung Julie
    McBride, Sean M.
    Tsai, Chiaojung J.
    Riaz, Nadeem
    Lee, Nancy Y.
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2020, 6 (04) : 17 - 28
  • [2] Proton therapy for tumors of the skull base
    Munzenrider, JE
    Liebsch, NJ
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (Suppl 2) : 57 - 63
  • [3] Proton therapy for tumors of the skull base
    John E. Munzenrider
    Norbert J. Liebsch
    Strahlentherapie und Onkologie, 1999, 175 : 57 - 63
  • [4] Proton therapy for tumors of the base of the skull
    Noel, Georges
    Gondi, Vinai
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (04)
  • [5] BRAIN INJURY AFTER PROTON THERAPY OR CARBON ION THERAPY FOR HEAD-AND-NECK CANCER AND SKULL BASE TUMORS
    Miyawaki, Daisuke
    Murakami, Masao
    Demizu, Yusuke
    Sasaki, Ryohei
    Niwa, Yasue
    Terashima, Kazuki
    Nishimura, Hideki
    Hishikawa, Yoshio
    Sugimura, Kazuro
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02): : 378 - 384
  • [6] Risk Factors for Radiation Necrosis and Local Recurrence after Proton Beam Therapy for Skull Base Chordoma or Chondrosarcoma
    Takahashi, Mizuki
    Mizumoto, Masashi
    Oshiro, Yoshiko
    Kino, Hiroyoshi
    Akutsu, Hiroyoshi
    Nakai, Kei
    Sumiya, Taisuke
    Ishikawa, Eiichi
    Maruo, Kazushi
    Sakurai, Hideyuki
    CANCERS, 2023, 15 (23)
  • [7] Temporal Lobe Toxicity Analysis After Proton Radiation Therapy for Skull Base Tumors
    Pehlivan, Berrin
    Ares, Carmen
    Lomax, Antony J.
    Stadelmann, Otto
    Goitein, Gudrun
    Timmermann, Beate
    Schneider, Ralf A.
    Hug, Eugen B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (05): : 1432 - 1440
  • [8] Proton beam therapy for intracranial and skull base tumors
    Mizumoto, Masashi
    Oshiro, Yoshiko
    Tsuboi, Koji
    TRANSLATIONAL CANCER RESEARCH, 2013, 2 (02) : 87 - 96
  • [9] Outcomes of adolescents and young adults treated for brain and skull base tumors with pencil beam scanning proton therapy
    Lim, Pei S.
    Tran, Sebastien
    Kroeze, Stephanie G. C.
    Pica, Alessia
    Hrbacek, Jan
    Bachtiary, Barbara
    Walser, Marc
    Leiser, Dominic
    Lomax, Antony J.
    Weber, Damien C.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (12)
  • [10] Impact of Relative Biologic Effectiveness for Proton Therapy for Head and Neck and Skull-Base Tumors: A Technical and Clinical Review
    Holtzman, Adam L.
    Mohammadi, Homan
    Furutani, Keith M.
    Koffler, Daniel M.
    McGee, Lisa A.
    Lester, Scott C.
    Gamez, Mauricio E.
    Routman, David M.
    Beltran, Chris J.
    Liang, Xiaoying
    CANCERS, 2024, 16 (11)